Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups.

Asmann, Yan W; Parikh, Kaushal; Bergsagel, P Leif; Dong, Haidong; Adjei, Alex A; Borad, Mitesh J; Mansfield, Aaron S

Asmann, Yan W; Parikh, Kaushal; Bergsagel, P Leif; Dong, Haidong; Adjei, Alex A; Borad, Mitesh J; Mansfield, Aaron S.

Afiliación

Asmann YW; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Parikh K; Precision Cancer Therapeutics of Mayo Clinic's Center for Individualized Medicine, Rochester, MN, USA.
Bergsagel PL; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Dong H; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA.
Adjei AA; Departments of Immunology and Urology, Mayo Clinic, Rochester, MN, USA.
Borad MJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Mansfield AS; Precision Cancer Therapeutics of Mayo Clinic's Center for Individualized Medicine, Rochester, MN, USA.

NPJ Precis Oncol ; 5(1): 22, 2021 Mar 19.

Article en En | MEDLINE | ID: mdl-33742076

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google